Healthcare advertisers and their marketing partners face challenges that other direct to consumer advertisers may not necessarily be confronted with. Namely, the ever-evolving world of privacy regulation and the requirements enacted by the federal and state governments with the goal of helping preserve patient anonymity.

Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge. In a new webinar, sponsored by PurpleLab, experts explore how PurpleLab’s data solutions can help foster a deeper understanding of physician prescribing behavior.

As the pharmaceutical and healthcare media industries face unprecedented change, the Preparing for 2025 roundtable convened leading experts to chart a path forward. Against a backdrop of rising patient expectations, accelerating technological advancements, and increasing regulatory pressures, this collaborative forum sought to address critical challenges while uncovering collective alignment for sustainable success.

We are in the middle of an ongoing data-driven revolution in the pharmaceutical industry. Data and analytics are reshaping how companies approach sales and marketing strategies – and customer experience.

Pharmaceutical advertisers and companies must develop marketing strategies that are multilayered as third-party cookies become a liability. Audience-based solutions remain part of this, but marketers should collaborate with their agency and ad tech partners to integrate real-world data in the pre-campaign planning, campaign launch and optimization phases. Discuss differences in content consumption based on health conditions, compare web behavior vs. TV viewing habits and how healthcare-focused supply analysis can feed into SPO applications.

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

Amidst the backdrop of evolving privacy regulations and the phasing out of traditional digital identifiers, the video explores the essential strategies pharmaceutical advertisers must adopt to navigate these industry challenges and accurately assess the real-world outcomes they are achieving from their advertising. This is a video recording of a speaking session produced in partnership with…

Pharma brand managers have a data problem: namely, they have access to so much of it that it can inundate their decision-making processes. We outline the best ways of streamlining the volume of information and separating the proverbial wheat from the chaff. This is a video recording of a speaking session produced in partnership with…